Friday, 21 Feb 2020

PsA/SpA

Date Typesort ascending Title Save
07 Nov 2017 Social RT @Janetbirdope: #GAMECHANGER. Ankylosing spondylitis genetics are biased AS parent is more likely to have AS in sons #acr17 @rheumnow #1
13 Feb 2020 Social 1st Jan inhibitor in AS - upadacitinib, it works! Drs Ruderman/Kavanaugh #RWCS2020 @RWCSmtg https://t.co/KLJh43h7pz
29 Sep 2017 Social Higher MASEI (enthesitis) scores in PsA assoc w/ more Jt damage, ankylosis, arthritis mutilans periostitis, axial Dz https://t.co/NKw37wkka5
14 Oct 2018 Social RheumNow Wk in Review is up! Info on SSc-SSLE overlap, capillaroscopy fingers, Women with SpA, acute gout management and lupus patients in pain in the ED. Watch here https://t.co/wB10SaVXF7 Or checkout the podcasts at iTunes or here https://t.co/5GdSlCyWmW
14 Jul 2016 Social in 428 SpA pts, BMI (obesity) has no effect on ASDAS. BMI weakly correlates w/ CRP, other PRO's. https://t.co/FcTfEicYpN
30 Sep 2019 Social Tofacitinib therapy is being studied (not yet approved) in several dermatologic conditions - psoriasis, alopecia areata/universalis, vitiligo, atopic dermatitis and dermatomyositis. https://t.co/Ez3u95Eh7K
08 Feb 2016 Social Acute sacroiliitis Dx by bone or CT scan. Causes include pyogenic infx, brucellosis, crystal induced, neoplasia https://t.co/toLl8suM0i
29 Dec 2017 Social Causes of Dactylitis = PsA, AS, SpA, reactive arthritis, MCTD, PSS, TB, syphilis, JIA, Sarcoid https://t.co/nhotKuYF2n
17 Feb 2017 Social RT @DrRachelTate: Tofa as an option for AS? No FDA indication but a potential off label option. E. Ruderman MD #rwcs2017 @RWCSmtg @RheumNow…
29 May 2018 Social Certolizumab is now FDA approved for use in Crohns disease, Rheumatoid arthritis, Ankylosing spondylitis, psoriatic arthritis and now Psoriasis.https://t.co/QVpmv7V9PI
27 Jul 2015 Social Having cholecystectomy-confirmed gallstones was assoc w/ risk of psoriasis (RR 2·20) & concomitant PsA (RR 4·41) http://t.co/xW9BuiTQHR
07 Nov 2017 Social RT @Lupusdoc: Poster title of the day....! #2556 @RheumNow #ACR17 https://t.co/nDmsAQQS19
13 Jan 2019 Social QD Video on RheumNow - an HLA-B27+ patient with Iritis, Enthesitis, Diarrhea. https://t.co/LusZttdAyw
15 Sep 2016 Social RT @RonanTKavanagh: patients with psoriatic spondyloarthritis more steroid responsive than patients with Ank Spond (60% vs 20% at week 2. #…
11 Nov 2019 Social RT @EBRheum: RCT Tildrakizumab (IL23i) in Psoriatic Arthritis Beat PLBO for ACR20 (NNT~4), ACR50 (NNT~4), and pt global (NNT~3 for 50% imp…
12 Nov 2019 Social RT @philipcrobinson: Use of complementary and alternative medicines in #psoriatic arthritis Abs 2462 #ACR19 @RheumNow https://t.co/h8UTbOwW…
02 May 2016 Social Health Canada approves secukinumab for use in psoriatic arthritis and anklylosing spondylitis https://t.co/TmmJyBXf24
02 Nov 2017 Social Low persistence of TNFi in PsA >2.5x more likely in women & pts w/ metabolic syndrome-related comorbidities https://t.co/F2VG1qOOAV
27 Mar 2018 Social Survey of 442 Dutch axial SpA patients finds Hidradenitis suppurativa twice as common (9.1% vs 4.1%) in AxSpA - HS/AxSpA more likely female with higher ASAS & BASDAI scores w/ more dactylitis & enthesitis. https://t.co/yJeyIr5uiM
21 Apr 2017 Social Valeant prices new Psoriasis drug Siliq (brodalumab) at $42,000/yr. undercutting price of other IL-17 drugs. https://t.co/mfu0ZWWkvv